Trial Profile
Pharmacokinetics Study of Posaconazole in Haematology Patients Receiving Standard of Care Treatment With Oral Posaconazole Prophylaxis for Invasive Fungal Infection
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2023
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- Acronyms POPULAR
- 27 Mar 2023 Planned End Date changed from 30 Jun 2023 to 30 Dec 2023.
- 27 Mar 2023 Planned primary completion date changed from 30 Jun 2023 to 30 Dec 2023.
- 27 Mar 2023 Status changed from active, no longer recruiting to recruiting.